Longevity Biomedical (Longevity Biomedical) Price-to-Operating-Cash-Flow : (As of May. 20, 2024)

View and export this data going back to 2050. Start your Free Trial

What is Longevity Biomedical Price-to-Operating-Cash-Flow?

As of today (2024-05-20), Longevity Biomedical's share price is $0.00. Longevity Biomedical does not have enough years/quarters to calculate the Cash Flow from Operations per share for the trailing twelve months (TTM) ended in . 20. Therefore GuruFocus does not calculate Price-to-Operating-Cash-Flow Ratio at this moment.

The historical rank and industry rank for Longevity Biomedical's Price-to-Operating-Cash-Flow or its related term are showing as below:

LBIO's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 27.11
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Longevity Biomedical's Cash Flow from Operations per share for the six months ended in . 20 was $0.00.

Longevity Biomedical Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Longevity Biomedical's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Longevity Biomedical Price-to-Operating-Cash-Flow Chart

Longevity Biomedical Annual Data

Trend

Price-to-Operating-Cash-Flow

Longevity Biomedical Semi-Annual Data

Price-to-Operating-Cash-Flow

Competitive Comparison of Longevity Biomedical's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Longevity Biomedical's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Longevity Biomedical's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Longevity Biomedical's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Longevity Biomedical's Price-to-Operating-Cash-Flow falls into.

Longevity Biomedical Price-to-Operating-Cash-Flow Calculation

Longevity Biomedical's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.00	/
	=

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Longevity Biomedical Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Longevity Biomedical's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Longevity Biomedical (Longevity Biomedical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Longevity Biomedical Inc (NAS:LBIO) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

12100 NE 195th street, Suite 150, Bothell, WA, USA, 98011

Website

https://www.longevitybiomedical.com

Longevity Biomedical Inc is a clinical-stage biomedical company. The company is focused on the advancement of new technologies across therapeutics, monitoring, and digital health that aim to restore tissue form and function to increase health span. Longevity is acquiring a differentiated therapeutic pipeline of late-stage clinical technologies across ophthalmology, cardiovascular disease, and soft tissue reconstruction and repair.

Longevity Biomedical (Longevity Biomedical) Headlines

No Headlines